Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

1,428 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,428 results

Not applicableWithdrawnNCT07195617
What this trial is testing

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Early research (Phase 1)Not Yet RecruitingNCT07720843
What this trial is testing

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Montefiore Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00664378
What this trial is testing

Efficacy Study of CYT997 in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Gilead Sciences 5
Testing effectiveness (Phase 2)Study completedNCT03439293
What this trial is testing

Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Multiple Myeloma
Takeda 61
Testing effectiveness (Phase 2)UnknownNCT03940833
What this trial is testing

Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM

Who this might be right for
Multiple Myeloma
Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00866138
What this trial is testing

Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3

Who this might be right for
Multiple Myeloma
AB Science 24
Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Not applicableLooking for participantsNCT05160584
What this trial is testing

Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Janssen Pharmaceutica N.V., Belgium 300
Very early researchUnknownNCT04186052
What this trial is testing

Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Looking for participantsNCT04910568
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genentech, Inc. 186
Testing effectiveness (Phase 2)Study completedNCT01593410
What this trial is testing

Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 194
Early research (Phase 1)UnknownNCT04727008
What this trial is testing

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sichuan University 12
Not applicableNo Longer AvailableNCT05503550
What this trial is testing

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Early research (Phase 1)UnknownNCT05007418
What this trial is testing

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sorrento Therapeutics, Inc. 54
Testing effectiveness (Phase 2)UnknownNCT01002703
What this trial is testing

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leipzig 50
Early research (Phase 1)Ended earlyNCT04123418
What this trial is testing

WVT078 in Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma (MM)
Novartis Pharmaceuticals 56
Early research (Phase 1)Looking for participantsNCT06799026
What this trial is testing

Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
David Avigan 25
Testing effectiveness (Phase 2)Study completedNCT00044018
What this trial is testing

CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 102
Next Page